yuanyuan shi

Mr. yuanyuan shi

On the job

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 April 2017 in BMC Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
FCFafeng Cheng
Fafeng Cheng
CMChongyang Ma
Chongyang Ma
XWXueqian Wang
Xueqian Wang
CZChangming Zhai
Changming Zhai
GWGuoli Wang
Guoli Wang
CCcongai cong chen
congai cong chen
Nonalcoholic fatty liver disease (NAFLD) represents one of the most common forms of liver disease worldwide, and it is always regarded as a consequence of a sedentary, food-abundant lifestyle, sitting for an extended time, and a low physical activity level, which often coincide with chronic and long-lasting psychological stress. A Chinese medicine Sinisan (SNS) may be a potential formula for treating this kind of disease. In this study, a long-term chronic restraint stress protocol was used to investigate the mechanism underlying stress-induced NALFD. To investigate the effect of SNS treatment on stress-induced NAFLD, we measured the liver and serum values of total cholesterol (TC), triglyceride (TG), liver free fatty acids (FFA), low-density lipoprotein, superoxide dismutase, tumor necrosis factor-α, malondialdehyde, interleukin (IL)-6, and serum values of aspartate aminotransferase (AST), alanine aminotransferase (ALT), and alkaline phosphatase. Results are shown as a mean ± standard deviation. Significant differences between the groups were evaluated using the Student t-test. For multiple comparisons, one-way analysis of variance (ANOVA) was used. If the results of ANOVA indicated significant differences, post hoc analysis was performed with the Tukey test or Dunnett test, and p < 0.05 was considered statistically significant. Long-term chronic stress led to steatosis and non-alcoholic steatohepatitis. Additionally, SNS treatment significantly increased body weight gain (p < 0.01) and sucrose preference (p < 0.001), and it reduced the liver values of TC, TG, and FFA (p < 0.05). SNS also reduced the serum values of AST and ALT (p < 0.001), and the liver value of IL-6 (p < 0.01). This study’s results demonstrate that psychological stress may be a significant risk factor of NAFLD. Furthermore, the traditional Chinese medicine formula SNS may have some beneficial effect in antagonizing psychological stress and stress-related NAFLD.


23 November 2023 in Pharmaceutical Science Advances
Verified
Journal Article
Open access
DGDongyang Gao
Dongyang Gao
WGWenli Gao
Wenli Gao
ZZZhiguang Zhai
Zhiguang Zhai
YSyuanyuan shi
yuanyuan shi
Idiopathic pulmonary fibrosis (IPF), a progressive lung disease characterized by irreversible lung dysfunction caused by fibroblast proliferation and excessive collagen deposition, is the result of persistent chronic inflammation of the lung parenchyma. Although the pathogenesis is not fully understood, the role of immune mechanisms such as innate immune response, adaptive immunity and immune regulation, and cytokines in the pathophysiological mechanism of pulmonary fibrosis have been gradually recognized. There are currently limited drugs available to treat IPF, and long-term use of these drugs may have many adverse effects. With the elucidation of the underlying immunological pathogenesis, the development of more valuable drugs targeting the immune system becomes possible. This review introduces the immunological pathogenesis of pulmonary fibrosis and the emerging drugs targeting the immune system in recent years, aiming to provide insights into the mechanism and treatment direction of pulmonary fibrosis.

10 February 2022 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
LWLu Wang
Lu Wang
YSyuanyuan shi
yuanyuan shi
RSRui Sun
Rui Sun
JLJing Liu
Jing Liu
QMQihong Ma
Qihong Ma
YSYuanyuan Shi
Yuanyuan Shi
Background. Pulmonary fibrosis (PF) is a devastating lung disease, resulting in gas exchange dysfunction until death. The two drugs approved by the FDA, pirfenidone and nintedanib, have obvious side effects. Wen-yu-jin (WYJ), one of the commonly used herbs in China, can treat respiratory diseases. The potential effects and the underlying mechanism of WYJ against PF are unclear. Purpose. Employing network pharmacology, molecular docking, and in vivo and in vitro experiments to explore the potential effects and underlying mechanisms of WYJ in the treatment of PF. Methods. Ultra-high pressure liquid chromatography combined with linear ion trap-orbital tandem mass spectrometry (UHPLC-LTQ-orbital trap) was used to identify compounds of WYJ. We got PF-related targets and WYJ compounds-related targets from public databases and further completed critical targets exploration, network construction, and pathway analysis by network pharmacology. Molecular docking predicted binding activity of WYJ compounds and critical targets. Based on the above results, in vivo and in vitro experiments validated the potential effects and mechanisms of WYJ against PF. Results. 23 major compositions of WYJ were identified based on UHPLC-LTQ-Orbitrap. According to the results of network pharmacology, STAT3, SRC, IL6, MAPK1, AKT1, EGFR, MAPK8, MAPK14, and IL1B are critical therapeutic targets. Molecular docking results showed that most of the compounds have good binding activities with critical targets. The results of in vivo and in vitro experiments showed that WYJ alleviated the process of fibrosis by targeting MAPK and STAT3 pathways. Conclusion. Network pharmacology, molecular docking, and in vivo and in vitro experiments showed the potential effects and mechanisms of WYJ against PF, which provides a theoretical basis for the treatment of WYJ with PF.

10 May 2025 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
HWHua Wu
Hua Wu
WSWen Sun
Wen Sun
ZZZiyuan Zeng
Ziyuan Zeng
QDQi Ding
Qi Ding
YSYuanyuan Shi
Yuanyuan Shi
YSyuanyuan shi
yuanyuan shi

15 April 2026 in International Journal of Molecular Medicine
Verified
Journal Article
Open access
PDF file
YCYeyang Chen
Yeyang Chen
HWHua Wu
Hua Wu
XWXiangjian Wu
Xiangjian Wu
LCLikun Che
Likun Che
XFXiaoyan Fu
Xiaoyan Fu
YSyuanyuan shi
yuanyuan shi
Influenza A (H1N1) virus‑induced pneumonia poses a significant clinical challenge because of excessive immune activation and limited targeted therapies. While current antivirals suppress viral replication, they fail to control absent in melanoma 2 (AIM2) inflammasome‑mediated hyperinflammation, a key driver of immunopathology and mortality. The present study investigated whether triptolide (TP) ameliorates H1N1‑induced pneumonia by targeting this unmet need. The results demonstrated that H1N1 infection reduced the levels of inflammatory cytokines in both human bronchial epithelial cells (HBEpiCs) and THP‑1 cells and decreased the adhesion between the two cell types. Furthermore, high‑dose H1N1 activation triggered the AIM2 signaling pathway in THP‑1 cells but not in HBEpiCs and decreased the viability of THP‑1 cells. In vitro and in vivo experiments both confirmed that TP effectively inhibited inflammation in alveolar epithelial cells and immune cells, as well as the adhesion between these cell types. Additionally, TP reduced the viral load of H1N1 in a murine pneumonia model. Further studies revealed that TP inactivated the AIM2 signaling pathway in THP‑1 cells but not in HBEpiCs. However, overexpression of AIM2 in THP‑1 cells markedly reversed the anti‑inflammatory effects of TP. Based on these findings, it was hypothesized that TP modulates the immune response by inactivating the AIM2 signaling pathway in immune cells, which reduces excessive immune cell activation and decreases the harmful interactions between immune cells and alveolar epithelial cells, ultimately alleviating the lung inflammation induced by H1N1 virus infection. The present study proposed a novel mechanism by which TP alleviates lung damage by suppressing AIM2‑driven immune hyperactivation in immune cells, thereby reducing harmful crosstalk with epithelial cells. This is the first evidence of AIM2‑targeted therapy positioning TP as a promising candidate for treating viral pneumonia.